Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Episurf Medical B | EPISB | Apr 19, 2024 | 0.71 | +0.14 |
EQL Pharma | EQL | Apr 19, 2024 | 42.70 | +1.18 |
EQT | EQT | Apr 19, 2024 | 288.10 | -0.52 |
Ericsson A | ERICA | Apr 19, 2024 | 57.10 | +0.53 |
Ericsson B | ERICB | Apr 19, 2024 | 56.30 | +0.79 |
ES Energy Save Holding | ESGRB | Apr 19, 2024 | 34.95 | +1.30 |
Essity A | ESSITYA | Apr 19, 2024 | 254.50 | 0.00 |
Essity B | ESSITYB | Apr 19, 2024 | 254.50 | +0.51 |
Euroafrica Digital Ventures | EURA | Apr 19, 2024 | 0.04 | -3.55 |
Eurobattery Minerals | BAT | Apr 19, 2024 | 0.38 | -1.82 |
Eurocine Vaccines | EUCI | Apr 19, 2024 | 0.07 | -29.04 |
European Institute of Science B | EURIB | Apr 19, 2024 | 4.00 | -15.97 |
Everysport Group AB | EVERY | Apr 19, 2024 | 17.50 | 0.00 |
Evolution | EVO | Apr 19, 2024 | 1 281.00 | -1.12 |
Ework Group AB. | EWRK | Apr 19, 2024 | 138.00 | +1.02 |
Exalt | EXALT | Apr 19, 2024 | 0.49 | -0.81 |
ExpreS2ion Biotech Holding | EXPRS2 | Apr 19, 2024 | 2.72 | +6.67 |
Exsitec | EXS | Apr 19, 2024 | 175.00 | -4.37 |
Eyeonid Group | EOID | Apr 19, 2024 | 13.44 | -7.31 |
Fabege | FABG | Apr 19, 2024 | 88.20 | +1.03 |
Fable Media Group AB | FABLE | Apr 19, 2024 | 4.90 | 0.00 |
Fagerhult Group AB | FAG | Apr 19, 2024 | 73.50 | -0.41 |
Fantasma Games | FAGA | Apr 19, 2024 | 42.40 | -0.93 |
Fasadgruppen | FG | Apr 19, 2024 | 68.80 | -0.29 |
Fastator | FASTAT | Apr 19, 2024 | 0.78 | +12.32 |
Fastout Int | FOUT | Apr 19, 2024 | 0.09 | 0.00 |
Fastpartner A | FPARA | Apr 19, 2024 | 74.50 | -0.80 |
Fastpartner D | FPARD | Apr 19, 2024 | 66.70 | +0.15 |
Fenix Outdoor B | FOIB | Apr 19, 2024 | 693.00 | +0.43 |
Ferroamp AB | FERRO | Apr 19, 2024 | 13.30 | -2.35 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.